Perifosine

What Perifosine Means in Everyday Medical Language

Perifosine is a drug that was studied as a potential treatment for cancer. It belongs to a group of drugs called alkylphospholipids, which are chemically related to natural fats found in cell membranes. Perifosine was designed to interfere with a specific cell signaling pathway known as the PI3K/AKT/mTOR pathway, which can play a role in cancer cell growth and survival. By targeting this pathway, perifosine aimed to slow down or stop cancer progression.

Why Perifosine Can Matter in Cancer Care

Although perifosine showed promise in early research and received special designations to encourage its development for rare cancers like multiple myeloma and neuroblastoma, later studies did not confirm its effectiveness. In 2012, a large clinical trial testing perifosine for colon cancer did not meet its goals, and further development for this use was stopped. Similarly, trials for multiple myeloma were discontinued in 2013. This means that while perifosine was once considered a hopeful new treatment, it is no longer being developed or used as a standard cancer therapy.

What Patients Might See or Hear About Perifosine

Patients or caregivers might come across the term perifosine in medical reports, clinical trial listings, or discussions about experimental treatments. It may appear in the context of past research studies or in historical treatment plans. Because perifosine is no longer an active treatment option, seeing this term can be confusing. It’s important to ask your care team what perifosine means for your specific case and whether it has any role in your current or future care.

Where Perifosine Might Appear

Perifosine may be mentioned in medical records, clinical trial summaries, or drug information pages related to cancer research. It might also appear in discussions about the PI3K/AKT/mTOR pathway or alkylphospholipid drugs. Since it was once under development for multiple myeloma and colon cancer, it could be referenced in those contexts. However, it is not part of standard treatment guidelines today.

What Perifosine Does Not Automatically Mean

Seeing the word perifosine does not mean a patient has a certain diagnosis or that this drug is currently recommended or available for treatment. It is not a diagnosis, a confirmed effective treatment, or a standard part of cancer care. Instead, it is the name of a drug that was studied but ultimately did not prove effective enough to become a regular treatment.

How to Use This Information and Next Steps

This information is meant to help patients and caregivers understand what perifosine is and why it might come up in cancer care discussions. It does not provide medical advice or recommendations. If you see perifosine mentioned in your medical records or hear about it from your care team, the best step is to ask how it relates to your individual situation. Your care team can explain whether it has any relevance to your diagnosis, treatment options, or clinical trials. Always consider perifosine in the full context of your care rather than as a standalone term.

Remember, cancer treatment is highly personalized, and new drugs are constantly being studied. Perifosine is an example of a drug that was researched but did not become a standard treatment. Staying informed and asking questions will help you and your caregivers make the best decisions together with your healthcare providers.